PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Inc.

Investors seeking all of the latest and greats stock market stories for Friday will find them in our daily roundup.


Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!

In a report released on December 1, Manjari Dhar from RBC Capital maintained a Sell rating on Pets at Home, with a price target of p190.00. The com...

Pets at Home (PETS) Gets a Sell from RBC Capital

In a report released yesterday, Alison Lygo from Deutsche Bank reiterated a Buy rating on Pets at Home, with a price target of p230.00. According t...

Deutsche Bank  Sticks to Its Buy Rating for Pets at Home (PETS)

Barclays analyst Richard Taylor maintained a Sell rating on Pets at Home on November 26 and set a price target of £1.80. The company’s shares close...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PETS	$3.55	+3.80%	266.81K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PETS	$3.55	+3.8%	266.81K
3
4
5
6

PETS

PETS

Get PetMed Express Inc. Data in Excel

Get PetMed Express Inc. Data in Excel